Comparison 5. Chemotherapy ± interleukin‐2.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
5.1 Overall survival | 2 | 644 | Hazard Ratio (IV, Random, 95% CI) | 0.95 [0.82, 1.11] |
5.2 Progression‐free survival | 1 | 363 | Hazard Ratio (IV, Random, 95% CI) | 0.87 [0.70, 1.08] |
5.3 Tumour response | 3 | 735 | Risk Ratio (M‐H, Random, 95% CI) | 0.85 [0.64, 1.13] |